The Transformative Potential of Lipid Nanoparticle–Protein Corona for Next-Generation Vaccines and Therapeutics
Molecular Pharmaceutics · 06.11.2023 · 20 (11) · 5247-5253
DOI: 10.1021/acs.molpharmaceut.3c00479 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, online erschienen am 02.10.2023. Verfasst von Augusto Amici und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Biosciences and Veterinary Medicine, University of Camerino, Via Gentile III da Varano, 62032 Camerino, Italy. Hauptthemen laut MEDLINE: Protein Corona, Vaccines. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The integration of the lipid nanoparticle (LNP)-protein corona as a pioneering approach for the development of vaccines against the present and future SARS-CoV-2 variants of concern marks a significant shift in the field. This concept holds great promise, offering a universal platform that can be adaptable to combat future pandemics caused by unknown viruses. Understanding the complex interactions among the protein corona, LNPs, and receptors is crucial for harnessing its potential. This knowledge will allow optimal vaccine formulations and improve their effectiveness. Safety assessments are essential to ensure suitability for human use, compliance with regulatory standards, and rigorous quality control in manufacturing. This transformative workflow requires collaborative efforts, expanding our foundational knowledge and translating advancements from the laboratory to clinical reality. The LNP-protein corona approach represents a paradigmatic shift with far-reaching implications. Its principles and insights can be leveraged beyond specific applications against SARS-CoV-2, enabling a universal platform for addressing viral threats, cancer, and genetic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biosciences and Veterinary Medicine, University of Camerino, Via Gentile III da Varano, 62032 Camerino, Italy.
- NanoDelivery Lab, Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 291, 00161 Rome, Italy.
ORCID-Profile: Giulio Caracciolo
Zitieren
APA
Amici, A., Pozzi, D., Marchini, C., & Caracciolo, G. (2023). The Transformative Potential of Lipid Nanoparticle–Protein Corona for Next-Generation Vaccines and Therapeutics. Molecular Pharmaceutics, 20(11), 5247-5253. https://doi.org/10.1021/acs.molpharmaceut.3c00479
Vancouver
Amici A, Pozzi D, Marchini C, Caracciolo G. The Transformative Potential of Lipid Nanoparticle–Protein Corona for Next-Generation Vaccines and Therapeutics. Molecular Pharmaceutics. 2023;20(11):5247-5253. doi:10.1021/acs.molpharmaceut.3c00479
BibTeX
@article{Amici2023,
author = {Amici, Augusto and Pozzi, Daniela and Marchini, Cristina and Caracciolo, Giulio},
title = {The Transformative Potential of Lipid Nanoparticle–Protein Corona for Next-Generation Vaccines and Therapeutics},
journal = {Molecular Pharmaceutics},
year = {2023},
volume = {20},
number = {11},
pages = {5247--5253},
doi = {10.1021/acs.molpharmaceut.3c00479}
}
EUVIMED